4.7 Article

CCR2+ monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-1

期刊

JOURNAL OF PATHOLOGY
卷 243, 期 3, 页码 320-330

出版社

WILEY
DOI: 10.1002/path.4956

关键词

immunosuppression; inflammation; myeloid cells; lung fibrosis; carbon nanotubes; silica; TIMP

资金

  1. Actions de Recherche Concertees, Federation Wallonie-Bruxelles [ARC 09/14-021, 14/19-056]
  2. Fondation Contre le Cancer [2012-219, 2014-148, 2014-150]
  3. Fonds de la Recherche Scientifique (FNRS) [PDR T.0119.13, CDR J0049.16]
  4. European Commission under FP7-HEALTH-F4 [202047]

向作者/读者索取更多资源

Monocytes infiltrating scar tissue are predominantly viewed as progenitor cells. Here, we show that tissue CCR2(+) monocytes have specific immunosuppressive and profibrotic functions. CCR2(+) monocytic cells are acutely recruited to the lung before the onset of silica-induced fibrosis in mice. These tissue monocytes are defined as monocytic myeloid-derived suppressor cells (M-MDSCs) because they significantly suppress T-lymphocyte proliferation in vitro. M-MDSCs collected from silica-treated mice also express transforming growth factor (TGF)-1, which stimulates lung fibroblasts to release tissue inhibitor of metalloproteinase (TIMP)-1, an inhibitor of metalloproteinase collagenolytic activity. By using LysMCreCCR2(loxP/loxP) mice, we show that limiting CCR2(+) M-MDSC accumulation reduces the pulmonary contents of TGF-1, TIMP-1 and collagen after silica treatment. M-MDSCs do not differentiate into lung macrophages, granulocytes or fibrocytes during pulmonary fibrogenesis. Collectively, our data indicate that M-MDSCs contribute to lung fibrosis by specifically promoting a non-degrading collagen microenvironment. Copyright (C) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据